Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Bitton

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
Patient Education and Counseling|August 2, 2017
Patients' perception of their involvement in shared treatment decision making: Key factors in the treatment of inflammatory bowel diseaseSophie Veilleux, Isabelle Noiseux, Nathalie Lachapelle, et al.
Inflammatory Bowel Diseases|April 18, 2014
Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and managementRobert Battat, Uri Kopylov, Andrew Szilagyi, et al.
Digestive Diseases and Sciences|December 9, 2019
Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD CenterJason Reinglas, Lorant Gonczi, Christine Verdon, et al.
Journal of Clinical Medicine|July 29, 2025
Impact of Individual Colonic Segment Histological Activity on Disease Relapse in Patients with Ulcerative ColitisSteven Li Fraine, Victoria Marcus, Chelsea Maedler Kron, et al.
World Journal of Gastroenterology|January 2, 2026
Clinical outcomes and drug sustainability after non-medical switch from ustekinumab originator to biosimilars in inflammatory bowel diseaseJustin Kritzinger, Ivanna Candel, Gynter Kotrri, et al.
The American Journal of Gastroenterology|October 24, 2003
Psychosocial determinants of relapse in ulcerative colitis: a longitudinal studyAlain Bitton, Maida J Sewitch, Mark A Peppercorn, et al.
Immunohorizons|September 9, 2024
Improving Reliability of Immunological Assays by Defining Minimal Criteria for Cell FitnessSabine Ivison, Gabrielle Boucher, Grace Zheng, et al.
The American Journal of Gastroenterology|September 21, 2020
Novel Negative Pressure Box for Aerosol Protection During Upper Endoscopy: A Brief Report on Safety and Barrier PerformanceAmine Benmassaoud, Alan Barkun, Anne V Gonzalez, et al.
Inflammatory Bowel Diseases|August 1, 2008
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot studyKelvin T Thia, Uma Mahadevan, Brian G Feagan, et al.
Canadian Journal of Gastroenterology & Hepatology|December 3, 2021
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel DiseasePanu Wetwittayakhlang, Farah Albader, Petra A Golovics, et al.
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Patient Education and Counseling|August 2, 2017
Patients' perception of their involvement in shared treatment decision making: Key factors in the treatment of inflammatory bowel diseaseSophie Veilleux, Isabelle Noiseux, Nathalie Lachapelle, et al.
Inflammatory Bowel Diseases|April 18, 2014
Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and managementRobert Battat, Uri Kopylov, Andrew Szilagyi, et al.
Digestive Diseases and Sciences|December 9, 2019
Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD CenterJason Reinglas, Lorant Gonczi, Christine Verdon, et al.
Journal of Clinical Medicine|July 29, 2025
Impact of Individual Colonic Segment Histological Activity on Disease Relapse in Patients with Ulcerative ColitisSteven Li Fraine, Victoria Marcus, Chelsea Maedler Kron, et al.
World Journal of Gastroenterology|January 2, 2026
Clinical outcomes and drug sustainability after non-medical switch from ustekinumab originator to biosimilars in inflammatory bowel diseaseJustin Kritzinger, Ivanna Candel, Gynter Kotrri, et al.
The American Journal of Gastroenterology|October 24, 2003
Psychosocial determinants of relapse in ulcerative colitis: a longitudinal studyAlain Bitton, Maida J Sewitch, Mark A Peppercorn, et al.
Immunohorizons|September 9, 2024
Improving Reliability of Immunological Assays by Defining Minimal Criteria for Cell FitnessSabine Ivison, Gabrielle Boucher, Grace Zheng, et al.
The American Journal of Gastroenterology|September 21, 2020
Novel Negative Pressure Box for Aerosol Protection During Upper Endoscopy: A Brief Report on Safety and Barrier PerformanceAmine Benmassaoud, Alan Barkun, Anne V Gonzalez, et al.
Inflammatory Bowel Diseases|August 1, 2008
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot studyKelvin T Thia, Uma Mahadevan, Brian G Feagan, et al.
Canadian Journal of Gastroenterology & Hepatology|December 3, 2021
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel DiseasePanu Wetwittayakhlang, Farah Albader, Petra A Golovics, et al.
Pageof 20